BMI-1, a promising therapeutic target for human cancer

MC Wang, CL Li, J Cui, M Jiao, T Wu… - Oncology …, 2015 - spandidos-publications.com
… In conclusion, BMI‑1 may represent a promising target for the prevention and therapy of … In
conclusion, BMI-1 may represent a promising target for the prevention and therapy of various …

The dual kinase complex FAK-Src as a promising therapeutic target in cancer

V Bolós, JM Gasent, S López-Tarruella… - … and therapy, 2010 - Taylor & Francis
Focal adhesion kinase (FAK) and steroid receptor coactivator (Src) are intracellular (nonreceptor)
tyrosine kinases that physically and functionally interact to promote a variety of cellular …

Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia

P Gallipoli, G Giotopoulos… - Therapeutic advances in …, 2015 - journals.sagepub.com
… to the identification of multiple rational therapeutic targets. Whilst these have provided new
… we can fully optimize and realize the promise of epigenetic therapies. The most prosaic of …

XIAP: apoptotic brake and promising therapeutic target

M Holcik, H Gibson, RG Korneluk - Apoptosis, 2001 - Springer
… cascade make the control of XIAP expression an exceptionally promising molecular target
for modulating apoptosis. Therapeutic benefits can be derived from both the suppression of …

NLRP3: a promising therapeutic target for autoimmune diseases

HH Shen, YX Yang, X Meng, XY Luo, XM Li… - Autoimmunity …, 2018 - Elsevier
… complex may serve as a promising and novel therapeutic target for clinical treatment in …
in autoimmune diseases, as well as their potential as therapeutic target for these diseases. …

[HTML][HTML] Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets

DP Ramji, TS Davies - Cytokine & growth factor reviews, 2015 - Elsevier
Atherosclerosis, a chronic inflammatory disorder of the arteries, is responsible for most deaths
in westernized societies with numbers increasing at a marked rate in developing countries…

Promising therapeutic targets for antileishmanial drugs

KA Werbovetz - Expert opinion on therapeutic targets, 2002 - Taylor & Francis
Current treatments for the parasitic disease leishmaniasis are unsatisfactory due to their
route of administration, toxicity and expense. Resistance is also developing to first-line …

[HTML][HTML] Arginase: An emerging and promising therapeutic target for cancer treatment

F Niu, Y Yu, Z Li, Y Ren, Z Li, Q Ye, P Liu, C Ji… - Biomedicine & …, 2022 - Elsevier
Arginase is a key hydrolase in the urea cycle that hydrolyses L-arginine to urea and L-ornithine.
Increasing number of studies in recent years demonstrate that two mammalian arginase …

IL-6/STAT3 is a promising therapeutic target for hepatocellular carcinoma

J Xu, H Lin, G Wu, M Zhu, M Li - Frontiers in oncology, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is a common malignant tumor of which the occurrence and
development, the tumorigenicity of HCC is involving in multistep and multifactor interactions. …

MMP-12, a promising therapeutic target for neurological diseases

B Chelluboina, KR Nalamolu, JD Klopfenstein… - Molecular …, 2018 - Springer
… Based on the reported studies to date, MMP-12 suppression could emerge as a
promising therapeutic target for several CNS diseases that were discussed in this review. …